GETZID MR 30 MG TABLET

GETZID MR 30 MG TABLET contains Gliclazide as its active ingredient. It belongs to the class of medications known as sulfonylurea antidiabetic agents. Gliclazide is used in the management of type 2 diabetes mellitus to help control blood sugar levels.

Mechanism of Action:

Gliclazide works by stimulating the release of insulin from the pancreatic beta cells. It acts primarily by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to depolarization of the cell membrane, calcium influx, and subsequent insulin release. This mechanism helps to lower blood sugar levels by increasing insulin secretion.

Uses:

GETZID MR 30 MG TABLET is indicated for the treatment of type 2 diabetes mellitus. It is used to help control blood sugar levels in patients whose diabetes cannot be adequately controlled by diet and exercise alone.

Dosage and Administration:

The dosage of GETZID MR 30 MG TABLET may vary depending on individual patient factors such as the severity of diabetes and response to treatment. It is typically taken orally once daily with breakfast or the first main meal of the day. The dosage should be adjusted based on blood glucose monitoring and under the supervision of a healthcare professional.

Side Effects:

Common side effects associated with GETZID MR 30 MG TABLET may include:

• Hypoglycemia (low blood sugar)
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Skin rash or itching

Precautions:

• Patients should be monitored regularly for signs and symptoms of hypoglycemia, especially when initiating therapy or adjusting the dosage of GETZID MR 30 MG TABLET.
• Use with caution in patients with hepatic impairment, as gliclazide is primarily metabolized by the liver.
• GETZID MR 30 MG TABLET should be used cautiously in elderly patients and those with renal impairment, as they may be at increased risk of hypoglycemia.
• Patients should be advised to avoid alcohol consumption while taking GETZID MR 30 MG TABLET, as it may increase the risk of hypoglycemia.

Conclusion:

GETZID MR 30 MG TABLET, containing gliclazide, is an oral antidiabetic medication used for the management of type 2 diabetes mellitus. By stimulating insulin release from pancreatic beta cells, gliclazide helps to lower blood sugar levels in diabetic patients. However, it is essential to use this medication cautiously and under the supervision of a healthcare professional to minimize the risk of hypoglycemia and other potential side effects.